Teriflunomid-Mepha 14 mg
Teriflunomid-Mepha 14 mg is a medicine authorised by Swissmedic under authorisation number 68744. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 September 2023 and the authorisation is limited until 31 August 2026. ATC code L04AA31 places the medicine in the group Immunosuppressants.
| Authorisation number | 68744 |
|---|---|
| Name | Teriflunomid-Mepha 14 mg |
| Full name | Teriflunomid-Mepha 14 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AA31 |
| First authorisation | 22 September 2023 |
| Authorisation validity | 31 August 2026 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Teriflunomid-Mepha 14 mg, Filmtabletten | B | 22 September 2023 |
| 2 | Teriflunomid-Mepha 14 mg QOD, Filmtabletten | B | 22 September 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L04AA31 | 01.99.0. | B |
| 2 | 84 | Tablette(n) | L04AA31 | 01.99.0. | B |
| 3 | 28 | Tablette(n) | L04AA31 | 01.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Teriflunomid-Mepha 14 mg authorised in Switzerland?
Yes. Teriflunomid-Mepha 14 mg is authorised by Swissmedic under authorisation number 68744, data as of 01 September 2026. The authorisation is limited until 31 August 2026.
Which dispensing category does Teriflunomid-Mepha 14 mg have?
Teriflunomid-Mepha 14 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Teriflunomid-Mepha 14 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.